Nature Protocols General Biochemistry, Genetics and Molecular Biology
Solid-phase synthesis of sterically hindered peptides via ribosome-mimicking molecular reactors
Abstract
Ribosome-mimicking molecular reactor (RMMR) facilitates rapid on-resin proximity-induced acyl transfer to form amide bonds, bypassing the kinetically hindered two-phase acylation process in conventional solid-phase peptide synthesis (SPPS). The RMMR-SPPS strategy exhibits excellence in the synthesis of difficult peptides containing sterically hindered amino acids ( N -methylated and/or α,α-disubstituted amino acids), far surpassing other methods. The assembly of RMMR on commercial resins is straightforward under standard SPPS conditions. Peptides containing sterically hindered amino acids are attractive drug leads owing to their enhanced stability and bioavailability. Here, a protocol is described to efficiently synthesize such peptides by mimicking ribosomal chemistry on solid phase. The incorporation of N -methylated or α,α-disubstituted amino acids into peptides can markedly enhance their drug-like properties by improving proteolytic stability and membrane permeability. However, the solid-phase synthesis of such sterically hindered peptides remains a persistent challenge. Here we present a detailed protocol based on our recently developed ribosome-mimicking molecular reactor (RMMR) strategy, which substantially improves the synthetic efficiency of these difficult sequences via solid phase peptide synthesis (SPPS). This protocol provides a comprehensive, step-by-step procedure to facilitate a quick startup by the users, including the synthesis of Oxyma-C as the key activating unit precursor in the RMMR structure, the preparation of RMMR resin through modification of conventional SPPS resin and implementation of RMMR-SPPS in both manual and automated synthesizer formats. Peptides containing N -methylated and/or α,α-disubstituted amino acid(s) are synthesized efficiently using our strategy, with crude purities of up to 98% and respectable isolated yields, greatly surpassing existing methods. It is anticipated that this approach will facilitate broader adoption of RMMR-SPPS, addressing critical technical gaps and accelerating the discovery of orally bioavailable or intracellularly targeted macrocyclic peptide drug candidates.